These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 11342956)

  • 1. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
    Moriyama MT; Glenton PA; Khan SR
    J Urol; 2001 May; 165(5):1687-92. PubMed ID: 11342956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men.
    Marengo SR; Resnick MI; Yang L; Chung JY
    J Urol; 1998 May; 159(5):1444-50. PubMed ID: 9554330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
    Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
    J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis.
    Marengo SR; Chen D; MacLennan GT; Resnick MI; Jacobs GH
    J Urol; 2004 Mar; 171(3):1304-8. PubMed ID: 14767338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
    Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
    Atmani F; Mizon J; Khan SR
    Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inter-alpha-inhibitor and its related proteins in experimentally induced calcium oxalate urolithiasis. Localization of proteins and expression of bikunin gene in the rat kidney.
    Atmani F; Glenton PA; Khan SR
    Urol Res; 1999; 27(1):63-7. PubMed ID: 10092155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bikunin prevents adhesion of calcium oxalate crystal to renal tubular cells in human urine.
    Ebisuno S; Nishihata M; Inagaki T; Umehara M; Kohjimoto Y
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S436-40. PubMed ID: 10541279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-alpha-inhibitor in calcium stones.
    Dawson CJ; Grover PK; Kanellos J; Pham H; Kupczyk G; Oates A; Ryall RL
    Clin Sci (Lond); 1998 Aug; 95(2):187-93. PubMed ID: 9680501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of inter-alpha-inhibitor and several of its derivatives on calcium oxalate crystallization in vitro.
    Dean C; Kanellos J; Pham H; Gomes M; Oates A; Grover P; Ryall R
    Clin Sci (Lond); 2000 Apr; 98(4):471-80. PubMed ID: 10731483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin E therapy prevents hyperoxaluria-induced calcium oxalate crystal deposition in the kidney by improving renal tissue antioxidant status.
    Thamilselvan S; Menon M
    BJU Int; 2005 Jul; 96(1):117-26. PubMed ID: 15963133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of bikunin mRNA in renal epithelial cells after oxalate exposure.
    Iida S; Peck AB; Byer KJ; Khan SR
    J Urol; 1999 Oct; 162(4):1480-6. PubMed ID: 10492241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of osteopontin in rat kidneys: induction during ethylene glycol induced calcium oxalate nephrolithiasis.
    Khan SR; Johnson JM; Peck AB; Cornelius JG; Glenton PA
    J Urol; 2002 Sep; 168(3):1173-81. PubMed ID: 12187263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin inhibits renal crystal retention in a rat stone forming model.
    Tsujihata M; Momohara C; Yoshioka I; Tsujimura A; Nonomura N; Okuyama A
    J Urol; 2008 Nov; 180(5):2212-7. PubMed ID: 18804815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.